Results 1 - 8 of 8 Search Tips

Nursing support during treatment of multiple myeloma with proteasome inhibitors

05 July 2018

Cancer Nursing Practice

evidence and practice

In the past two years proteasome inhibitors have risen in prominence reflecting the recent approval of two new agents, carfilzomib and ixazomib. This means there are...

Practical experience with rituximab subcutaneous

08 October 2015

Cancer Nursing Practice


Treatment regimens involving the monoclonal anti-CD20 antibody rituximab are the standard of care for patients with CD20-positive non-Hodgkin lymphoma (NHL). It has...

An overview of non-Hodgkin’s lymphoma

11 February 2014

Cancer Nursing Practice


Non-Hodgkin’s lymphoma is a heterogeneous group of lymphoproliferative malignancies with differing patterns of behaviour and responses to treatment. Chemotherapy,...

A screening tool to identify frailty in older people with lymphoma and help assess treatment and social support needs

30 May 2018

Cancer Nursing Practice

frailty tool

By 2020, two million people aged 65 and over will be living with a cancer diagnosis, and about 14,000 people are diagnosed with lymphoma each year. Assessment...

Role of clinical nurse specialists in supporting people with chronic cancer to develop expertise in their condition

09 October 2023

Cancer Nursing Practice

evidence and practice

Background The lifting of the coronavirus disease 2019 (COVID-19) pandemic restrictions in the UK has meant a near-full return to normal life for the general...

Patient concerns after haematopoietic stem cell transplantation: an evaluation

16 February 2024

Cancer Nursing Practice

evidence and practice

As survival rates among patients receiving haematopoietic stem cell transplantation (HSCT) improve, there is increased recognition of patients’ long-term needs. In...

Acute promyelocytic leukaemia: reviewing outcomes of induction treatment with arsenic trioxide and retinoic acid

07 February 2022

Cancer Nursing Practice

Cancer treatments

Acute promyelocytic leukaemia (APL) is a rare subtype of acute myeloid leukaemia with high mortality rates. Chemotherapy-based regimens have demonstrated...

Continuing professional development: lymphoma in primary care

07 May 2019

Primary Health Care

blood cancer

Lymphoma encompasses a heterogeneous group of haematological malignancies that require complex management. Patients with lymphoma experience a wide range of...